Home
Local News
Weather
Eyewitness Sports
HealthBeat
Call For Action
Investigators
Technology
Entertainment
Community
What's On WPRI
What's On Fox
Contests
2 Min Test Drive
Experts Online
Feedback
Online Store
Station Info



MARKETPLACE:  Auto | Jobs | Personals | Yellow Pages  August 19, 2004
LIFESTYLE: 
Education | House & Home | Money | Pets | Recipes | Relationships | Travel | Weddings
What's Next | More Topics...
Peter Garcia named Chief Financial Officer of Nanosys
Email to a Friend Printer Friendly Version  

PALO ALTO, Calif., Aug. 9 /PRNewswire/ -- Nanosys, Inc., a leading nanotechnology company, today announced that Peter S. Garcia has joined the company as its Chief Financial Officer.

Mr. Garcia brings extensive executive expertise to Nanosys with over 19 years experience in various financial roles at both start-up and public biotechnology and high technology companies. Prior to Nanosys, Mr. Garcia was Senior Vice President and Chief Financial Officer of Nuvelo Inc. , a biopharmaceutical company. During his tenure at Nuvelo, he helped raise over $150 million, acquired development stage products, and led the merger and acquisition strategy. Prior to Nuvelo, Mr. Garcia served as Chief Financial Officer for Novacept Inc., IntraBiotics Pharmaceuticals, and Dendreon Corporation. He was instrumental in raising over $500 million for these companies. His prior financial operations experience comes from Amgen Inc. and Teradata Corporation where he held a variety of financial management positions. Mr. Garcia has an M.B.A. from the Anderson School at University of California Los Angeles and a B.A. in Economics and Sociology from Stanford University.

"We are extremely pleased with Pete joining the Nanosys team," says Calvin Chow, Nanosys CEO and co-founder. "Pete's demonstrated accomplishments across multiple industries from computing to biotechnology make him ideal for addressing the diverse and numerous opportunities that Nanosys is presented with."

Peter Garcia said, "I am excited and energized at the opportunity to be joining a company with the potential to develop products that revolutionize the way companies do business. Nanosys' technology, intellectual property, and scientific and business leadership provide a compelling competitive advantage in the field of nanotechnology."

About Nanosys

Nanosys, Inc. is a leader in the development of nanotechnology based products utilizing inorganic nanostructures. Nanosys has built one of the broadest technology platforms in the industry with more than 250 patents and patent applications covering fundamental areas of nanotechnology. Based in Palo Alto, Calif., Nanosys collaborates with industry leaders including Dupont, Intel, Matsushita Electric Works and SAIC to develop revolutionary high-value, high-performance products for computing, optoelectronics, communications, energy, defense and the life and physical sciences.

Contact: Calvin Chow CEO, Nanosys, Inc. [email protected] (650) 331-2100

CONTACT: Calvin Chow, CEO of Nanosys, Inc., +1-650-331-2100,[email protected]

Web site: http://www.nanosysinc.com/

Disclaimer: Information contained on this page is provided by companies featured through PR Newswire. PR Newswire, WorldNow and this Station cannot confirm the accuracy of this information and make no warranties or representations in connection therewith.

Latest Health News  more» 
Scientists Close In on Cleft Palate Genes
Blood, Tissue Donations Getting Safer
Vitamin E Thwarts Colds in the Elderly
Anthrax Scare at U.S. Embassy in Malaysia
Nicotine Patches Help Teens Quit Smoking
Iacocca Launches Campaign to Fund Diabetes Research
FDA Approves Device to Treat Stroke
Nicotine Patches Help Teens Quit Smoking
Major HIV Drug Trial Stopped
Brain Disease Rates Soaring, Pollution Link Cited
Learn something new!
Scholarships, school search, and WIN $500!
Aaaaachoo!
Suffering from allergies? Learn to beat them!
Get the Facts
Free Alzheimer's tips & info by mail!
Car of the Future
Exciting auto advances from the experts.
Get in touch today!
Find friends, family, lost loves, military buddies, or anyone else you wish to reconnect with here.
Send questions and comments about this website to the .
All content © Copyright 2004 WorldNow, WPRI, WNAC and Associated Press. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.